Secretion of Glucagon-like peptide-1 (GLP-1), Glucose-dependent insulinotropic polypeptide (GIP), insulin and glucagon and glucose disposal in patients with NAFLD and NASH vs. controls in response to oral glucose tolerance test.

Patients n = 52; controls n = 50. Data are expressed as mean±SEM. AUC, area under the curve; cmax, maximum plasma concentration. Multiple Mann-Whitney tests with Bonferroni-Holm adjustment of p-values for multiplicity of testing. P≤0.05, statistically significant difference; ns, not significant.